

         ##### ProP v.1.0b ProPeptide Cleavage Site Prediction #####


         ##### Furin-type cleavage site prediction (Arginine/Lysine residues) #####


 1439 661         
MPYLGIYDVITNPNMAEAVTGSGKTLAFLIPVLEMLWREKWSASQGLGALVITPTRELAYQIYEVLKKIGCKHDFSAGLV      80
IGGKSIDEERSRLACTNIVIATPGRLLQHMDQTSTFSCDLLQMLVLDEADRILDMGFSTAMKYILENLPEERQTLLFSAT     160
LSNPSIIKLANLSLKEGVIVSTNKTNKTPNQLSHAYVTVDLSEKLEVLYAFIKSHLNSKILVFMSSCKQVQFHNAVLCKL     240
RPGVPILALYGKQKQLRRVGIYESFCKKTSAVLLATDIAARGLDIPAVHWVVHLDCAEDVETYIHRSGRTARYHKAGNSL     320
AMILPSEEAFIDNLQKHGVTLTKIRVNPQKQISIQKKVQSMCAESQEVHHWAKKTFNSYVRSVFLQRDKTVFDVNKLPLS     400
AYAASLGLLSAPKVRFLKKAEKKRGGDGEGEEQEESDKEEENEGDEGDQDDSEAEEAKKAFSALADDNDDDDILVKKDSS     480
VMDSLSTDNLEALQPRQTKKKAKSKVAKAKALLKKGIKVNTKISFDEEGNVEAQEGAFDRQPAAALVDITPAIDPAKAGG     560
IDIDEMQKDMRDRDTEDKATAKQRRKEAKLEKKEKRKRVRGEEAPVAVLGGCSESEEGEEEQEPEEKRHCSSLQETEDLA     640
AHLLGDLQIYNTVIFLFVQIKYYAINCLVLFTLFLSISLDGVNTDLFVILLKGSKILSGLGELSLLHTLTDVPVDEGSFG     720
VHEIELVVKSGPCLSDGSGVGQHAHGPLDLGEVTSGNNGGWLVVDANLETSGAPVDELDGPLGLDGGNGSVDVLGDDITP     800
VQHTTGHVLSVSGIALDHLVGRLEASVGDLSNGELLVVGLLSGDDGSVGHQREVNPGVGHQVGLELSQINVKGTIESQRS     880
GDGGDDLSNQPVQVGVGRSLDVQVPSADIVDSLVVNHEGTVGVLKGGMGGQDRVVGLNDSGGDLGRGVDGELQLRLLSVV     960
NTEPLAEQRGQTGSGTSTEGVEDEESLESSTLVSLRIREGLAIQYICRDLFIQFHFPDSVQNKINDLLSDGVVTSGVVVS    1040
GILLASDQLFRVEELSVSSSSDLIDDGGLQINKHSPGDVLSSSSLAEEGVEGVISTSDGLVRGHLTVGLDTVLQAVEFPA    1120
GITNLDSGLSNVDRDTFTHDEEREFRDLWQSGVGHQVGLELSQINVKGTIESQRSGDGGDDLSNQPVQVGVGRSLDVQVP    1200
SADIVDGLIVDHEGTVGVLQGGMGGQDRVVGLNDSGGDLGRGVDGELQLRLLSVVNTEPLAEQRGQTGSGTSTEGVEDEE    1280
SLESSTLVSLRIREGLAIQYICRDLFIQFHFPDSVQNKINDLLSDGVVTSGVVVSGILLASDQLFRVEELSVSSSSDLID    1360
DGGLQINKHSPGDVLSSSSLAEEGVEGVISTSDGLVRGHLTVGLDTVLQAVEFPAGITNLDSGLSNVDRDTFTHDEERG     1440
................................................................................      80
................................................................................     160
................................................................................     240
................................................................................     320
................................................................................     400
................................................................................     480
................................................................................     560
................................................................................     640
................................................................................     720
................................................................................     800
................................................................................     880
................................................................................     960
................................................................................    1040
................................................................................    1120
................................................................................    1200
................................................................................    1280
................................................................................    1360
...............................................................................     1440
 
Propeptide cleavage sites predicted:	Arg(R)/Lys(K): 0





